Applications of nanotech may provide bioavailability 26-Mar-2019 By Maggie Lynch Nanotechnology may be able to increase bioavailability in low-solubility drugs and improve a drug’s chance of success, according to Ascendia CEO.
Biologics market worth $158bn by 2015, new report Biologics market worth $158bn by 2015, new report 19-Aug-2010 Improving safety and efficacy coupled with drug industry desire for “stronger” patents will drive growth of the biologics sector over the next five years, according to new research.